Recall of Diabetes Drug Metformin Expanded
In January of 2021, drug maker Nostrum Laboratories voluntary recalled its popular diabetes drug metformin over concerns that it contained unacceptable levels of a cancer-causing agent. This latest recall involves one lot of 750 mg extended-release tablets. This recall is…
Read More